METASTATIC NON-SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON-SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON-SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON-SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
CRISPR injection targets tough lung cancer in liver
Disease control Not yet recruitingThis early-stage study tests a new gene-editing drug called EDB-102 in 15 adults with advanced non-small cell lung cancer that has spread to the liver and no longer responds to standard targeted therapy. The drug uses CRISPR technology to find and disable a specific cancer-causin…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Morning infusions may boost lung cancer treatment
Symptom relief Not yet recruitingThis study tests if giving immunotherapy (pembrolizumab) in the morning works better than giving it at random times for people with advanced non-small cell lung cancer. About 58 participants will be split into two groups: one gets infusions only between 8-10 AM, the other gets th…
Matched conditions: METASTATIC NON-SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Symptom relief
Last updated May 18, 2026 12:03 UTC